Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- ⚖️ [Sacramento, CA] Proposition 36 Rollout Falls Short of Treatment Promises as Felony Arrests Mount - davisvanguard.org
- 🚐 [Enfield, CT] CT’s first state-funded methadone vans expand access to treatment - ctmirror.org
- 💉 [Augusta, ME] 3 organizations to receive grants from opioid settlement funds - centralmaine.com
- 🍃 [Deerfield, Massachusetts] Massachusetts cracks down on kratom, following lead of local communities - gazettenet.com
🗣️ Social Pulse
Lived/Living Experience
- No posts found today.
Innovation
- 🚨 Northern Health and @fnha are issuing a Drug Advisory for the Northern Health Region. Recent drug samples of white Hydromorphine pills, sold as “Dilaudid” have tested positive for the new synthetic opioid... - @Northern_Health on X
- 📶 Retention in Telehealth-Delivered Buprenorphine Treatment for Opioid Use Disorder: Multistate Retrospective Cohort Study. (link) - @digitalhealthev on X
Opposition Views
🏙 City Updates
- No recent City Updates found.
📚 Academic Research
- 🏥 Articles You Might Have Missed - Journal of Medical Toxicology - 2026-08-14 - doi.org
- 💊 Medication transitions and predictors of illicit substance use during opioid agonist treatment: a three-year follow-up study - Addiction Science & Clinical Practice - 2026-08-14 - doi.org
- 🚑 Synthetische Opioide: Der Versuch, vor die Welle zu kommen - Sozialmagazin - 2026-08-13 - doi.org
⚖️ Law & Policy
- No hits in Law and Policy today.
💸 Funding
Current
- Deadline Approaching🚑 Office of National Drug Control Policy - Nonfatal Overdoses in Emergency Departments: Bridging Patient Characteristics, Biospecimen Toxicology, and Drug Supply Composition - Deadline: Aug 31, 2026
- 🔬 National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- 🔬 National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- 🔬 National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- 🔬 National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- 🔬 National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- 🩺 Hearst Foundations - Health - Hearst Foundations (Health) - Year-Round, Rolling Grant Application - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🏥 Hearst Foundations - Social Service - Hearst Foundations — Social Service (year-round rolling applications) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 💡 Smart Family Fund - Angel Philanthropy (first-time grants) - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch
📣 Activism
- No activism updates found.